Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
NovaBay Pharmaceuticals, Inc.
Pharmaceutical Preparations CA, United States
NYSE MKT: NBY
Company Description
NovaBay Pharmaceuticals Inc. is a clinical stage biotechnology company developing an anti-infective platform of compounds called the Aganocide compounds, for the treatment or prevention of infections in hospital and non-hospital environments. The company is developing commercial opportunities for its portfolio of anti-infectives Aganocide compounds in four healthcare markets: dermatology, ophthalmology, urology and hospital infections. It is also involved in developing NeutroPhase, a solution for cleansing and debriding wounds. The company was formerly known as NovaCal Pharmaceuticals, Inc. NovaBay Pharmaceuticals was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.
Similar to: GW Pharmaceuticals Plc, Sareum Holdings Plc, Trius Therapeutics, Inc.
Featured Company
Alexco Resource Corp.
Vancouver, BC, CA
Canadas Only Primary Silver Producer Alexco owns and operates the Bellekeno silver mine, Canadas only operating primary silver… Learn more →
Social Monitor
You may also be interested in:
Trius Therapeutics, Inc.
San Diego, CA, US
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics… Learn more →
Sareum Holdings Plc
Cambridge, EA, GB
Sareum is a drug discovery company, headquartered in Cambridge UK, that produces targeted small molecule therapeutics, focusing on… Learn more →
GW Pharmaceuticals Plc
Salisbury, WI, GB
GW Pharmaceuticals Plc researches and develops cannabinoid medicines. The companys principal activity is developing and manufacturing… Learn more →